Kimberly; Robert P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kimberly; Robert P..The latest application filed is for "antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof".

Company Profile

0.20.27

Kimberly; Robert P. - Birmingham AL
Kimberly, Robert P - Birmingham AL
KIMBERLY, ROBERT P. - CLOSTER NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof Grant 9,700,618 - Zhou , et al. July 11, 2	2017-07-11
Agents and methods related to screening for resistance to DR5 and reducing resistance to DR5 agonists Grant 9,528,993 - Zhou , et al. December 27, 2	2016-12-27
Antibody Selective For A Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptor And Uses Thereof App 20140308288 - Zhou; Tong ; et al.	2014-10-16
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 and uses thereof Grant 8,715,668 - Zhou , et al. May 6, 2	2014-05-06
Polymorphisms in the FCGR2B Promoter and Uses Thereof App 20140080125 - Kimberly; Robert P. ; et al.	2014-03-20
Agents and Methods Related to Reducing Resistance to Apoptosis-Inducing Death Receptor Agonists App 20130324433 - Zhou; Tong ; et al.	2013-12-05
Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof App 20130243780 - Zhou; Tong ; et al.	2013-09-19
Therapeutics And Processes For Treatment Of Immune Disorders App 20130195840 - Kimberly; Robert P. ; et al.	2013-08-01
Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists Grant 8,476,030 - Zhou , et al. July 2, 2	2013-07-02
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof Grant 8,329,180 - Zhou , et al. December 11, 2	2012-12-11
Agents and Methods Related to Reducing Resistance to Apoptosis-Inducing Death Receptor Agonists App 20120122724 - Zhou; Tong ; et al.	2012-05-17
Antibody Selective For A Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptor And Uses Thereof App 20120076792 - Zhou; Tong ; et al.	2012-03-29
Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists Grant 8,129,124 - Zhou , et al. March 6, 2	2012-03-06
Biomarkers for cancer sensitivity and uses thereof Grant 8,119,355 - Kimberly , et al. February 21, 2	2012-02-21
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof Grant 8,067,001 - Zhou , et al. November 29, 2	2011-11-29
Process For Regulating Immune Response App 20110268753 - Kimberly; Robert P. ; et al.	2011-11-03
Combinations of antibodies selective for DR5 and other therapeutic agents Grant 7,981,421 - Zhou , et al. July 19, 2	2011-07-19
Polymorphisms In The Fcgr2b Promoter And Uses Thereof App 20110039713 - KIMBERLY; ROBERT P. ; et al.	2011-02-17
Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof App 20110008324 - Zhou; Tong ; et al.	2011-01-13
Combinations Of Antibodies Selective For Dr5 And Other Therapeutic Agents App 20110002887 - Kimberly; Robert P. ; et al.	2011-01-06
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof Grant 7,790,165 - Zhou , et al. September 7, 2	2010-09-07
Biomarkers for Cancer Sensitivity and Uses Thereof App 20100173338 - Kimberly; Robert P. ; et al.	2010-07-08
Agents and Methods Related to Reducing Resistance To Apoptosis-Inducing Death Receptor Agonists App 20100135951 - Zhou; Tong ; et al.	2010-06-03
Biomarkers for cancer sensitivity and uses thereof Grant 7,713,525 - Kimberly , et al. May 11, 2	2010-05-11
Combinations of antibodies selective for DR5 and other therapeutic agents Grant 7,704,502 - Zhou , et al. April 27, 2	2010-04-27
Antibody Selective For Dr4 And Uses Thereof App 20090208483 - Zhou; Tong ; et al.	2009-08-20
Combinations of Antibodies Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Other Therapeutic Agents App 20090022707 - Kimberly; Robert P. ; et al.	2009-01-22
Antibody selective for DR4 and uses thereof Grant 7,476,383 - Zhou , et al. January 13, 2	2009-01-13
Polymorphisms in the Fcgr2b Promoter and Uses Thereof App 20080248465 - Kimberly; Robert P. ; et al.	2008-10-09
Biomarkers For Cancer Sensitivity And Uses Thereof App 20080096235 - Kimberly; Robert P. ; et al.	2008-04-24
Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof App 20070298039 - Zhou; Tong ; et al.	2007-12-27
Combinations of DR5 antibodies and other therapeutic agents Grant 7,279,160 - Zhou , et al. October 9, 2	2007-10-09
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof Grant 7,244,429 - Zhou , et al. July 17, 2	2007-07-17
Genetic polymorphism in the receptor for IgA Grant 6,986,987 - Kimberly January 17, 2	2006-01-17
Genetic polymorphism in a complement receptor App 20040121393 - Kimberly, Robert P.	2004-06-24
Genetic polymorphism in a complement receptor Grant 6,664,052 - Kimberly December 16, 2	2003-12-16
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof App 20030198637 - Zhou, Tong ; et al.	2003-10-23
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof App 20030190687 - Zhou, Tong ; et al.	2003-10-09
Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents App 20030133932 - Zhou, Tong ; et al.	2003-07-17
B lymphocyte stimulator (BLyS) as a marker in management of systemic lupus erythematosus App 20020150579 - Kimberly, Robert P. ; et al.	2002-10-17
Diagnostic Test Using Fc Receptor App 20010014460 - KIMBERLY, ROBERT P. ; et al.	2001-08-16
FC receptor polymorphism Grant 5,985,561 - Kimberly , et al. November 16, 1	1999-11-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.